Aspen Neuroscience (ASPE) vs Inovio Pharmaceuticals (INO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aspen Neuroscience is the larger company by market cap ($361.2 million vs $329.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASPE | INO |
|---|---|---|
| Share price | $12.42 | $1.76 |
| Market cap | $361.16M | $329.66M |
| 1-day change | +0.24% | +2.92% |
| YTD return | — | +1.15% |
| 1-year return | — | 0.00% |
| 5-year return | — | -97.98% |
| EPS (TTM) | $-4.89 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $65.34K |
| Revenue growth (YoY) | — | -69.99% |
| Net income (latest FY) | — | $-84.95M |
| Operating margin | — | -132871.32% |
| Net margin | — | -130000.00% |
| 52-week high | $14.90 | $2.72 |
| 52-week low | $11.20 | $0.56 |
| Distance from 52-week high | -16.64% | -35.29% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +259.66% |
| Average volume | 352.42K | 11.24M |
| Shares outstanding | 29.08M | 187.31M |
| Employees | 120 | 112 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aspen Neuroscience
ASPE stock →Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees
About Inovio Pharmaceuticals
INO stock →Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.
Health Care · Biotechnology: Pharmaceutical Preparations · 112 employees
ASPE vs INO FAQ
Which is bigger, Aspen Neuroscience or Inovio Pharmaceuticals?
Aspen Neuroscience (ASPE) is larger, with a market capitalization of $361.16M compared with $329.66M for Inovio Pharmaceuticals (INO).
Are Aspen Neuroscience and Inovio Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.